Corbus Pharmaceuticals

(NASDAQ) CRBP

Current Price$10.03

Market Cap$178.78M

Since IPO (2014)-89%

5 Year-82%

1 Year+25%

1 Month+16%

Corbus Pharmaceuticals Financials at a Glance

Market Cap

$178.78M

Revenue (TTM)

$0.00

Net Income (TTM)

$78.54M

EPS (TTM)

$-5.98

P/E Ratio

-1.69

Dividend

$0.00

Beta (Volatility)

1.24 (Average)

Dividend

$0.00

Beta (Volatility)

1.24 (Average)

Price

$10.03

Volume

Open

$10.06

Price

$10.03

Volume

Open

$10.06

Previous Close

$10.03

Daily Range

$9.94 - $10.74

52-Week Range

$6.10 - $20.56

Dividend

$0.00

Beta (Volatility)

1.24 (Average)

Price

$10.03

Volume

Open

$10.06

Previous Close

$10.03

Daily Range

$9.94 - $10.74

52-Week Range

$6.10 - $20.56

CRBP News

3 Stocks Robinhood Investors Love

Will HealyAug 16, 2020

Better Buy: GW Pharmaceuticals vs. Corbus Pharmaceuticals

Sushree MohantyJul 17, 2020

Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Corbus Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Yuval Cohen, PhD

Website

www.corbuspharma.com

Headquarters

Norwood, MA 02062, US

CRBP Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-54%

Return on Capital

-58%

Return on Assets

-47%

Earnings Yield

-59.17%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$178.78M

Shares Outstanding

17.74M

Volume

Avg. Volume

211.88K

Financials (TTM)

Gross Profit

$233.00K

Operating Income

$85.31M

EBITDA

$85.08M

Operating Cash Flow

$64.49M

Capital Expenditure

$7.00K

Free Cash Flow

$64.50M

Cash & ST Invst.

$163.94M

Total Debt

$1.63M

Corbus Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$49.00K

+66.4%

Gross Margin

0.00%

N/A

Market Cap

$178.78M

N/A

Market Cap/Employee

$6.39M

N/A

Employees

N/A

Net Income

$20.55M

-115.7%

EBITDA

$59.48M

+733.9%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$162.31M

+11.3%

Accounts Receivable

$1.50M

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$1.63M

+1.7%

Return on Assets

-46.69%

N/A

Return on Invested Capital

-57.84%

N/A

Free Cash Flow

$15.93M

-45.6%

Operating Cash Flow

$15.92M

-45.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

MOLNMolecular Partners AG

MOLNMolecular Partners AG$4.35-2.46%

MISTMilestone Pharmaceuticals Inc.

MISTMilestone Pharmaceuticals Inc.$1.86-1.59%

ELTXElicio Therapeutics, Inc.

ELTXElicio Therapeutics, Inc.$11.36-2.82%

IPHAInnate Pharma S.A.

IPHAInnate Pharma S.A.$1.40+1.45%

CRDFCardiff Oncology, Inc.

CRDFCardiff Oncology, Inc.$1.72-0.00%

PEPGPepGen Inc.

PEPGPepGen Inc.$1.60+3.90%

ALECAlector, Inc.

ALECAlector, Inc.$2.35-2.49%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

POETPoet Technologies

POETPoet Technologies$7.95-0.47%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$62.64+0.00%

NOKNokia

NOKNokia$10.71+0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$52.45-0.00%

INTCIntel

INTCIntel$84.99+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.32+0.01%

QQQInvesco QQQ Trust

QQQInvesco QQQ Trust$664.23+0.00%

Questions About CRBP

What is the current price of Corbus Pharmaceuticals?

Corbus Pharmaceuticals is trading at $10.03 per share.

What is the 52-week range for Corbus Pharmaceuticals?

Over the past 52 weeks, Corbus Pharmaceuticals has traded between $6.10 and $20.56.

How much debt does Corbus Pharmaceuticals have?

As of the most recent reporting period, Corbus Pharmaceuticals reported total debt of $1.63M.

How much cash does Corbus Pharmaceuticals have on hand?

Corbus Pharmaceuticals reported $29.16M in cash and cash equivalents in its most recent financial results.

What is Corbus Pharmaceuticals’s dividend yield?

Corbus Pharmaceuticals does not currently have a dividend yield.

Corbus Pharmaceuticals

Corbus Pharmaceuticals Financials at a Glance

CRBP News

Corbus (CRBP) Q2 Loss Beats Estimates

This Biotech Penny Stock Is Better Than Dogecoin

Why Corbus Pharmaceuticals Is Getting Slammed Today

2 Dirt-Cheap Robinhood Stocks That Could Skyrocket

3 Awful Stocks Robinhood Investors Love -- and 1 of the Best

Robinhood Investors Love These 3 Biotech Stocks. Should You?

3 Stocks Robinhood Investors Love

Better Buy: GW Pharmaceuticals vs. Corbus Pharmaceuticals

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Corbus Pharmaceuticals

CRBP Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Corbus Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CRBP

What is the current price of Corbus Pharmaceuticals?

What is the 52-week range for Corbus Pharmaceuticals?

How much debt does Corbus Pharmaceuticals have?

How much cash does Corbus Pharmaceuticals have on hand?

What is Corbus Pharmaceuticals’s dividend yield?

Premium Investing Services